KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBT (2009 - 2026)

Amgen's quarterly EBT came in at $2.1 billion in Q1 2026, up 5.63% year-on-year from $2.0 billion in Q1 2025, and up 37.65% quarter-over-quarter from $1.5 billion in Q4 2025.

Amgen has reported EBT for 18 years, with the latest figure at $2.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, EBT rose 5.63% year-over-year to $2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $9.1 billion (up 36.65% YoY), and the FY2025 full-year result was $9.0 billion, up 94.75% from the prior year.
  • EBT for Q1 2026 stood at $2.1 billion, up from $1.5 billion in the prior quarter.
  • The five-year high for EBT was $3.9 billion in Q3 2025, with the low at -$68.0 million in Q1 2024.
  • Average EBT over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2022.
  • Year-over-year, EBT sank 101.98% in 2024 and jumped 3001.47% in 2025.
  • Tracing AMGN's EBT over 5 years: stood at $1.7 billion in 2022, then tumbled by 51.26% to $852.0 million in 2023, then dropped by 8.22% to $782.0 million in 2024, then jumped by 93.61% to $1.5 billion in 2025, then jumped by 37.65% to $2.1 billion in 2026.
  • The last three EBT figures came in at $2.1 billion (Q1 2026), $1.5 billion (Q4 2025), and $3.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 8.85 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.99 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.04 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -3.50 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.08 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.58 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 3.17 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 3.24 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.08 Bn
Dec 31, 2025 1.51 Bn
Sep 30, 2025 3.92 Bn
Jun 30, 2025 1.57 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 782.00 Mn
Sep 30, 2024 3.10 Bn
Jun 30, 2024 794.00 Mn
Mar 31, 2024 -68.00 Mn
Dec 31, 2023 852.00 Mn
Sep 30, 2023 1.95 Bn
Jun 30, 2023 1.61 Bn
Mar 31, 2023 3.44 Bn
Dec 31, 2022 1.75 Bn
Sep 30, 2022 2.39 Bn
Jun 30, 2022 1.53 Bn
Mar 31, 2022 1.68 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 2.16 Bn
Jun 30, 2021 558.00 Mn
Mar 31, 2021 1.86 Bn
Dec 31, 2020 1.88 Bn
Sep 30, 2020 2.21 Bn
Jun 30, 2020 2.03 Bn
Mar 31, 2020 2.02 Bn
Dec 31, 2019 1.98 Bn
Sep 30, 2019 2.28 Bn
Jun 30, 2019 2.56 Bn
Mar 31, 2019 2.31 Bn
Dec 31, 2018 2.19 Bn
Sep 30, 2018 2.09 Bn
Jun 30, 2018 2.65 Bn
Mar 31, 2018 2.62 Bn
Dec 31, 2017 2.21 Bn
Sep 30, 2017 2.38 Bn
Jun 30, 2017 2.54 Bn
Mar 31, 2017 2.46 Bn
Dec 31, 2016 2.28 Bn
Sep 30, 2016 2.42 Bn
Jun 30, 2016 2.20 Bn
Mar 31, 2016 2.26 Bn
Dec 31, 2015 1.91 Bn
Sep 30, 2015 2.19 Bn
Jun 30, 2015 2.00 Bn
Mar 31, 2015 1.88 Bn
Dec 31, 2014 1.29 Bn
Sep 30, 2014 1.34 Bn
Jun 30, 2014 1.76 Bn
Mar 31, 2014 1.20 Bn
Dec 31, 2013 1.01 Bn
Sep 30, 2013 1.50 Bn
Jun 30, 2013 1.41 Bn
Mar 31, 2013 1.34 Bn
Dec 31, 2012 923.00 Mn
Sep 30, 2012 1.26 Bn
Jun 30, 2012 1.46 Bn
Mar 31, 2012 1.37 Bn
Dec 31, 2011 1.05 Bn
Sep 30, 2011 454.00 Mn
Jun 30, 2011 1.34 Bn
Mar 31, 2011 1.31 Bn
Dec 31, 2010 999.00 Mn
Sep 30, 2010 1.43 Bn
Jun 30, 2010 1.46 Bn
Mar 31, 2010 1.42 Bn
Dec 31, 2009 1.08 Bn
Sep 30, 2009 1.54 Bn
Jun 30, 2009 1.36 Bn
Mar 31, 2009 1.23 Bn